Technological Advancements in Single-cell Analysis Market Worth $5.6 billion by 2025 | Growing Focus on Personalized Medicine

single-cell analysis market

Single-cell Analysis Market Single-cell Analysis Market

PUNE, India, 2020-May-26 — /EPR Network/ —

[252 Pages Report] The Single-cell Analysis Market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.

Growth in this market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and bio-pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases. However, the high cost of single-cell analysis systems is expected to restrain the growth of this market during the forecast period.

Approach to calculate revenue of different players in the single-cell analysis market

The size of the global market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the market size for the segments. Further splits were applied to arrive at the market size for each subsegment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for North America.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

The human cells segment dominates the single-cell analysis market

Based on cell type, the market is segmented into human, animal, and microbial cells. The human cells segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the high utilization of human cells in research laboratories and academic institutes.

Research applications will continue to dominate the market during the forecast period

On the basis of application, the market is segmented into research (cancer, immunology, neurology, stem cell, and other research applications) and medical applications (noninvasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection). The research applications segment accounted for the largest market share in 2018. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.

Recent Developments in the Market:

  • In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been developed for consolidated targeted DNA and RNA enrichment and analyses. These panels save time and conserve samples that are of limited availability.
  • In July 2019, QIAGEN partnered with Illumina with the aim to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits.
  • In June 2019, Beckman Coulter acquired Cytobank, Inc. (US) to integrate Cytobank’s software into Beckman Coulter’s product portfolio to provide innovative solutions to customers.

Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254

The global market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, and growth in the outsourcing of drug discovery services to Asian CROs are some of the major factors driving the demand for single-cell analysis consumables and instruments in this regional market.

Key Market Players:

The single-cell analysis market is highly consolidated, with a few players competing for a larger market share. The top five players account for more than half of the total market share, while other global and regional market players account for the remaining share.

Prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany)

Matched content

Editor’s pick

Express Press Release Distribution